ARTHUR HAFFEY: Open Payments
NPI 1407014335 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 16 payments from 9 companies in 2025. Trend: 2023 $89 · 2024 $174 · 2025 $501
Food & beverage: $322Education: $179
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $185 |
| ABBVIE INC. | 4 | $104 |
| Merz Pharmaceuticals, LLC | 3 | $82 |
| Lundbeck LLC | 1 | $29 |
| Noctrix Health, Inc. | 1 | $24 |
| Cala Health, Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Medtronic, Inc. | 1 | $19 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
Products named: VYALEV, INBRIJA, Xeomin, BOTOX, VYEPTI, NIDRA, Cala kIQ, KESIMPTA.
Industry payments across OR — which companies pay providers there.
